ASIT KUMAR CHAKRABORTY

Dr. ASIT KUMAR CHAKRABORTY


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2022 in Current Research in Pharmacology and Drug Discovery
Verified
Journal Article
Open access
ACASIT KUMAR CHAKRABORTY
ASIT KUMAR CHAKRABORTY
SSSourajit Saha
Sourajit Saha
KPKousik Poria
Kousik Poria
TSTanmoy Samanta
Tanmoy Samanta
SGSudhanshu Gautam
Sudhanshu Gautam
JMJayanta Mukhopadhyay
Jayanta Mukhopadhyay
Gradual increase of multidrug resistant infections is a threat to the human race as MDR plasmids have acquired.>10 mdr and drug efflux genes to inactivate antibiotics. Plants secret anti-metabolites to retard growth of soil and water bacteria and are ideal source of antibiotics. Purpose of the study is to discover an alternate phyto-drug from medicinal plants of India that selectively kills MDR bacteria. MDR bacteria isolated from Ganga river water, milk, chicken meat and human hair for testing phyto-extracts. Eighty medicinal plants were searched and six phyto-extracts were selected having good antibacterial activities as demonstrated by agar-hole assays giving 15 ​mm or greater lysis zone. Phyto-extracts were made in ethanol or methanol (1:5 w/v) for overnight and were concentrated. Preparative TLC and HPLC were performed to purify phytochemical. MASS, NMR, FTIR methods were used for chemical analysis of CU1. In vitro RNA polymerase and DNA polymerase assays were performed for target identification. CU1 belongs to a saponin bromo-polyphenol compound with a large structure that purified on HPLC C18 column at 3min. CU1 is bacteriocidal but three times less active than rifampicin in Agar-hole assay. While in LB medium it shows greater than fifteen times poor inhibitor due to solubility problem. CU1 inhibited transcription from Escherichia coli as well as Mycobacterium tuberculosis RNA Polymerases. Gel shift assays demonstrated that CU1 interferes at the open promoter complex formation step. On the other hand CU1 did not inhibit DNA polymerase. Phyto-chemicals from Cassia fistula bark are abundant, less toxic, target specific and may be a safer low cost drug against MDR bacterial diseases.

1 January 2022 in Journal of Emerging Diseases and Virology
Verified
Journal Article
Open access
ACASIT KUMAR CHAKRABORTY
ASIT KUMAR CHAKRABORTY
NCBI SARS-CoV-2 Database was analyzed between November-December, 2021 to decipher the spread of Delta corona virus variants in the USA and compared with highly transmissible new omicron variant recently originated in South Africa.

4 January 2024 in Research Square
Verified
Preprint
Open access
PDF file
ACASIT KUMAR CHAKRABORTY
ASIT KUMAR CHAKRABORTY
The COVID-19 Spike protein 24LPP, 69HV, 143VYY, 156FR, 212L deletions, 215EPE and 249RWMD insertions were very well characterized. Changes in spike likely select RBD in a favorable 3-D structure to interact with ACE-2 receptor of human cells for coronavirus entry. Our goal is to characterize the newly spreading JN.1 subvariant and related omicron coronaviruses. BLASTP search found a 17MPLF four amino acid insertion in omicron BA.2.86 subvariant and its precedent JN.1 subvariant which had unique L452S (L455 in Wuhan) spike mutation. The JN.1 variant also contained 2375SGF deletion in ORF1ab, 24LPP, 69HV, 145Y, 211N (208N in BA.2) and 483V (480V in BA.2) deletions in the spike, 31ERS deletion in N-protein and 26nt deletion in 3’-UTR (NC_045512.2). Many unique JN.1 spike mutations (242N = H249N, 261D = A268D, 352T = K360T, 400K = R407K, 442H = P449H, 449W = L456W, 474K = N485K, 480K = A488K and 566V = A574V) might be also important. The BLASTN search with insertion oligo found over 3895 JN.1 related sequences in the NCBI Database and were well distributed in America and Europe but more monopartite JN.1 sequences deposited from Europe. Although, JN.1 acquired the 69HV deletion lately but did not generated from BA.4 or BA.5 lineages and it was solely generated from BA.2.86 variant. Swiss-Model detected a wing structure with basic amino acid in the middle of tripartite spike of JN.1 and important ACE-2 first interacting surface amino acids were changed. The small M protein of JN.1 had D3H, A63T and A104V mutations but Swiss Model showed no gross change in 3-D structure. Further, four JN.1 specific ORF1ab polyprotein mutations were detected: T170I mutation in nsp1 as well as D1600N, K1973R mutations in nsp3 protease and R3821K mutation in nsp6. Astonishingly, after a long journey of XBB.1.5.1 to XBB.1.5.100 subvariants spread, a sudden five amino acids deletion (176EGKEG and180EGKQG in Wuhan) in the spike of XBB.1.5.103 subvariant was found. The ORF8 immune-regulatory protein expression was abolished in all XBB.1 subvariants including XBB.1.5.103 and XBB.1.16.23 as expected due to termination codon mutations (AAA = TAA, CAA = TAA, GGA = TGA). But such ORF8 gene mutation (GGA = TGA) was also found in ongoing dominated JD.1.1, FL.1.5.1, HV.1 and EG.5.1.1 subvariants, derived from XBB.1 lineage. The FL.1.5.1 variant also has 82GHV deletion instead 82GHVMV in the nsp1 protein as well as a 27nt deletion (27887 5’-aac gaa cat gaa att tct tgt ttt ctt-3’) in the ORF7a gene. Partial or no expression of nsp1, ORF7a and ORF8 regulatory proteins cause coronavirus more immune deficient and less pathogenic. The spread of JN.1 has sent an alarm among health officials worldwide. It is worthwhile to see if JN.1 coronavirus goes nsp1 or OR7a deletion and ORF8 termination codon mutation with time lowering pathogenicity.

1 January 2018 in Journal of Molecular Medicine and Clinical Applications
Verified
Journal Article
Open access
ACASIT KUMAR CHAKRABORTY
ASIT KUMAR CHAKRABORTY
AMR spread is huge with millions of death due to ineffectiveness of antibiotics.

17 January 2023 in Research Square
Verified
Preprint
Open access
PDF file
ACASIT KUMAR CHAKRABORTY
ASIT KUMAR CHAKRABORTY
Alarming antibody evasion properties were documented for new BF, BQ and XBB Omicron subvariants. Most immune-drugs were inactive neutralizing those COVID-19 subvariants and viral titers were exceptionally low as compared to deadly B.1.1.7, B.1.617.2 and B.1.1.529 variants with D614G, N501Y and L452R mutations in spike. The 91% nucleotides changes in spike protein of BQ.1 were resulted in AA changes whereas only 52% nucleotides changes resulted in AAs changes in ORF1ab. The N460K and K444T mutations in BQ.1 may be important driving force for immune-escape similar to F486S and N480K mutations in BA.2.75 subvariant and related XBB.1 subvariant. Further, the R346T mutation as found in BA.4.6 and BF.7, was regained in BQ.1.1 and BA.2.75.2 to enhance immune escape and infectivity (> 80%). The L452R and F486V mutations in spike were main drivers of Omicron BA.2 conversion to BA.4 and BA.5 in presence of 69HV deletion. Whereas 24LPP spike deletion and 3675SGF ORF1ab protein deletion were found in all Omicron viruses including BQ.1 and XBB.1. Interestingly, we found about 211 COVID-19 sequences with four amino acids (249RWMD) insertion near the RBD domain of Omicron viruses similar to 215EPE three amino acids insertion in Omicron BA.1 variant. Such sequences first detected in California and extended to Florida, Washington and Michigan as well as other adjoining US states. An one amino acid deletion (140Y) in spike was also found in BA.4.6, BQ.1.5, BQ.1.8, BQ.1.14, BQ.1.1.5, XBB.1 as well as related AZ.3, BU.1, BW.1, CR.2, CP.1 and CQ.1 subvariants but was not detected in BA.2.75, BF.7, XBD, BQ.1, BQ.1.1, BQ.1.2, BQ.1.6, BQ.1.10, BQ.1.12, BQ.1.16, BQ.1.19, BQ.1.22, BQ.1.1.1, BQ.1.1.4, BQ.1.1.12 and related BK.1, BN.1, BM.1.1.1, BR.2, BU.1, CA.1, CD.2, CH.1.1 subvariants. Thus, BQ.1 insertion was compensated the other deletions and would be more infectious than BA.2.75, BF.7 and XBB.1 subvariants even there was a 26nt deletion in the 3’-UTR. The spike protein R341T one amino acid change in BQ.1.1 and BQ.1.1.1 might be important but no 249RWMD insertion.

16 July 2024 in Research Square
Verified
Preprint
Open access
PDF file
ACASIT KUMAR CHAKRABORTY
ASIT KUMAR CHAKRABORTY
We postulated a higher omicron JN.1/BA.2.86.1.1 coronavirus transmission due to unique 17MPLF spike insertion compensating 24LPP, 69HV, 145Y, 211N and 483V deletions [Journal of Future Medicine and Healthcare Innovation, 2(3):1–20, 2024]. After six months of our publication in Research Square preprint, I am updating our analysis of omicron spike insertion mutants. Database analysis suggested that JN.1-JN.1.25 subvariants had such insertion and such mutants were predominantly spreading worldwide. But we found some new coronavirus variants spread in the database like KP.1, KP.2, KP.1.1, KQ.1, XDD, XDK, XDP, XDQ, XDQ.1 and more which was contradictory to our hypothesis. Similarly, previously compared HV.1, EG.5.1.1, XBB.1.1-XBB.1.103, FL.1.5.1 like variants with no 17MPLF insertion but with termination codon mutation in the ORF8 gene, was diminishing comparatively in 2024. Surprisingly, the newly spreading subvariants also contained 17MPLF insertion in the spike. Originally, KP.1 was BA.2.86.1.1.11.1 while XDQ variant was a composite of BA.2.86.1 and FL1.5.1.1 suggesting JN.1, KP.1, XDK and XDQ subvariants were very similar. As the other genetic variations were found minimal, our hypothesis was fundamentally proved. On the other hand, critical search indicated omission of ORF8 protein in some 17MPLF insertion mutants likely diminishing viral load and disease severity but frequently found ORF7a deletions were not found. We also detected unique 32S deletion in the spike of few 17MPLF insertion mutants increasing to nine AAs spike deletion in JN.1 lineages. BLASTP search using oligopeptides at the new mutations (F59L, H146Q, R346T) and deletion (32S) boundaries demonstrated the penetration of insertion mutants in the USA, UK, Russia and Japan. Contrary to our hypothesis, Opentrons P (AN: PP889628, PP916105, PP938531, PP938533, PQ009953), Sadri N (AN: PP887470, PP88747474, PP887480, PP887481), Dragon J et al. (PP938086, PP938087), and Reev V et al (AN: PP871683, PP934270, PQ012208) reported JN.1 lineages without 17MPLF spike insertion.